Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $8.7 million.

  • Treace Medical Concepts' Cash from Investing Activities rose 5158.77% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year decrease of 8104.49%. This contributed to the annual value of $35.4 million for FY2024, which is 14351.22% up from last year.
  • Treace Medical Concepts' Cash from Investing Activities amounted to $8.7 million in Q3 2025, which was up 5158.77% from -$3.3 million recorded in Q2 2025.
  • Treace Medical Concepts' Cash from Investing Activities' 5-year high stood at $22.4 million during Q2 2024, with a 5-year trough of -$80.5 million in Q1 2023.
  • Its 5-year average for Cash from Investing Activities is -$6.4 million, with a median of -$900000.0 in 2021.
  • In the last 5 years, Treace Medical Concepts' Cash from Investing Activities crashed by 701244.44% in 2022 and then skyrocketed by 31522.59% in 2024.
  • Over the past 5 years, Treace Medical Concepts' Cash from Investing Activities (Quarter) stood at -$900000.0 in 2021, then tumbled by 7012.44% to -$64.0 million in 2022, then soared by 107.82% to $5.0 million in 2023, then tumbled by 31.68% to $3.4 million in 2024, then surged by 155.36% to $8.7 million in 2025.
  • Its Cash from Investing Activities stands at $8.7 million for Q3 2025, versus -$3.3 million for Q2 2025 and -$1.9 million for Q1 2025.